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Abstract
Background: The persistent left superior vena cava (PLSVC) is a relatively common con-
genital venous return anomaly. It may have serious clinical implications especially in case of 
pacemaker/cardioverter-defibrillator implantation, venous catheter insertion, radio-frequency 
ablation and cardiac surgery. There is also some evidence that PLSVC may be accompanied by 
arrhythmias. The aim of this report is to present the effectiveness and safety of cardiac pacing 
via PLSVC, clinical outcome and appearance of arrhythmias in a long-term follow-up.
Methods and results: Four cases of pacing electrodes implanted via PLSVC in patients 
without any other cardiac congenital heart anomalies were observed for at least 6 years. There 
was 1 patient with AAI, 2 patients with VVI, and 1 with DDD pacemaker. Atrial electrodes 
were implanted on the free right atrial wall, 2 ventricular electrodes were implanted in right 
ventricular outflow tract, 1 in postero-lateral cardiac vein. During the mean 110 months of 
observation, pacing was efficient. One patient underwent an upgrade from AAI to biatrial pac-
ing due to progressive interatrial conduction delay during the follow-up. No other intervention 
or pacemaker related events were noticed except for battery replacement.
Conclusions: The presence of PSVC may complicate implantation, but it does not influence 
the long-term follow-up of pacing parameters. (Cardiol J 2014; 21, 4: 413–418)
Key words: persistent left superior vena cava, congenital venous anomaly,  
pacemaker implantation, arrhythmia, atrial fibrillation
Introduction
The pacemaker (PM) implantation may cause 
some difficulties in case of persistent left superior 
vena cava (PLSVC) reported in approximately 
0.3–0.5% of the general population [1–3]. The 
abnormal early embryonic development of great 
thoracic veins may also result in abnormalities of 
the conduction tissue because of the proximity of 
these areas. In most cases (80%), there are double 
superior veins. Usually, PLSVC drains away to the 
markedly dilated coronary sinus (CS), and only spo-
radically to the left atrium (LA). Very rarely, there 
is a CS ostial atresia and PLSVC drains backward 
from CS to the right superior vena cava [4]. PLSVC 
occurs in 3–10% of patients with other congenital 
cardiac malformations, most often with the atrial 
septal defect. An important clinical implication 
of PLSVC is its influence on different types of 
arrhythmias [5–7]. There are some case reports 
concerning patients with PLSVC [8–12], but not 
a long-term observations after PM implantation.
Methods
There were 3,452 patients, who underwent 
PM implantation from October 1995 to December 
2006 in our center. Four cases of PLSVC patients 
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were enrolled for the observation. All the patients 
had fully documented clinical and electrocardio-
graphic (ECG) indications for PM implantation, 
and the procedures were performed using standard 
leads and pulse generators. After the discharge, 
regular visits took place in the out-patient clinic 
according to the scheme: 1 month, 3 months after 
implantation, and every 6 months during follow-up. 
An ambulatory ECG monitoring was performed to 
assess the presence of arrhythmias and efficacy 
of pacing. Clinical characteristics of 4 patients are 
presented in Table 1, and PM parameters in Table 2.
Patient 1 (Case 1). A 54-year-old man with 
tachycardia-bradycardia syndrome and a history of 
ischemic stroke was referred for PM implantation 
in 1997. The patient complained of palpitations, 
dizziness and syncopal episodes. At the time of 
implantation in a standard 12-lead ECG there was 
a normal sinus rhythm with PQ duration of 120 ms 
(P-wave duration 80 ms) but the 24-h ECG 
monitoring showed many episodes of atrial fibrilla-
tion (AF) which ended in pauses and severe sinus 
bradycardia. Trans-thoracic echocardiography did 
not show any significant structural changes. During 
the implantation procedure the left subclavian vein 
approach was not successful, therefore the J-shape, 
unipolar lead with a passive fixation was inserted 
via right subclavian vein. The route of the lead was 
unusual: it passed through the mediastinum from 
the right to the left side and then went down along 
the left border of the heart and turned to the right 
atrium (RA). The tip of the electrode was placed on 
the lateral wall of the RA because a RA appendage 
(RAA) could not be achieved. After the PM implan-
tation stimulus to Q wave interval (SQ) duration 
was 220 ms and P-wave duration was 160 ms. 
A contrast echocardiography was performed. The 
micro-bubbles appeared first in the dilated CS, than 
in the RA after the injection of contrast (cooled 
0.9% NaCl) to the left and right antecubital veins. 
Table 1. Baseline characteristics of patients (Pt.).
Pt. Sex Age 
[years]
Diagnoses Arrhythmia Type of venous 
anomaly
Tachy- Brady-
1 M 54 Paroxysmal AF Sinus bradycardia 
Interatrial block
Single left SVC
2 M 73 AH, CAD Paroxysmal AFL
Paroxysmal AF
Sinus bradycardia 
Sinoatrial block
Impaired AV conduction 
(measured during  
pacemaker implant)
Single left SVC
3 F 75 AH, CHF Permanent AF,  
ventricular arrhythmia 
Paroxysmal AV block Double SVC
4 M 75 AH, DM, CHF Permanent AF Paroxysmal AV block Single left SVC
AF — atrial fibrillation; AFL — atrial flutter; AH — arterial hypertension; AV — atrio-ventricular; CAD — coronary artery disease; CHF — con-
gestive heart failure; DM — diabetes mellitus; F — female; M — male; SVC — superior vena cava
Table 2. Pacemaker (PM) follow-up.
Pt. Pacing  
mode 
Follow-up  
period [month]
Threshold [V]  
(0.5 ms impulse width)
Sensing  
[mV]
Resistance  
[Ω]
At PM  
implant
After  
follow-up
At PM  
implant
After  
follow-up
At PM  
implant
After  
follow-up
1 AAI/AAT (BiA) 89 RA 0.7 RA 1.8 RA 2.4 2.0** RA 620 1200**
LA* 0.5 LA 4.2 LA* 2.4 LA* 530
2 DDDR  
(RA + RVOT)
84 A 0.4 
V 0.1
A 0.8 
V 0.7
A 2.2 
V 17.4
A 1.8 
V 23.6
A 640 
V 780
A 580 
V 690
3 VVI (LV) 48 1.1 1.5 20 15.7 1100 980
4 VVI (RVOT) 14 0.9 0.8 12.5 13.5 720 810
*Electrode for LA stimulation was placed 48 months after RA (pacing mode was changed); **measurement between RA and LA (interatrial); 
A — atrium; LA — left atrium; LV — left ventricle; RA — right atrium; RVOT — right ventricular outflow tract; Pt. — patient; V — ventricle
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Angiography was performed to confirm a single, 
left sided superior vena cava.
Despite antiarrhythmic treatment with 3 dif-
ferent drugs, the patient was hospitalized and car-
dioverted several times for paroxysmal AF. Biatrial 
stimulation (BiA) was considered an alternative. In 
April 2001, a bipolar electrode with an active fixa-
tion was inserted into the CS to pace the LA. Both 
leads were connected by a Y-connector to the SSI 
pacemaker (Fig. 1). In the described case, the RA 
electrode was a cathode and the CS electrode was 
an anode. BiA pacing reduced P wave duration and 
the SQ from 180 to 120 ms and 220 to 160 ms, re-
spectively. After the BiA system implantation, the 
patient was not hospitalized for paroxysmal AF and 
had only self-terminating palpitations. However, 
in 2005 his rhythm degenerated to a chronic AF.
Patient 2 (Case 2). A 73-year-old man with 
paroxysmal atrial flutter and AF followed by symp-
tomatic sinus bradycardia and paroxysmal sinoatrial 
block was presented for PM implantation. His 
echocardiogram revealed left ventricular (LV) hy-
pertrophy, mild mitral and aortic regurgitation. The 
dilated CS was noticed in a modified parasternal 
long-axis view with the diameter of 38 × 15 mm. 
The left sided approach was chosen for a PM im-
plantation. The course of advanced lead indicated 
the presence of PLSVC. The attempt to reach RAA 
was not successful and a bipolar active fixation lead 
was screwed in RA free wall. Next, bipolar passive 
fixation lead was placed in the right ventricular 
outflow tract (RVOT). The presence of PLSVC was 
confirmed by angiography and the trans-esophageal 
echocardiography. No other malformations were 
found. Amiodarone (200 mg/day) was prescribed 
to prevent existing supra ventricular tachyarrhyth-
mias with a good clinical effect.
Patient 3 (Case 3). A 75-year-old woman 
with a congestive heart failure and permanent AF 
was admitted due to syncope, palpitations, weak-
ness and exercise intolerance. Holter monitoring 
documented many episodes of severe bradycardia 
< 35/min. Trans-thoracic echocardiography revealed 
mildly impaired LV ejection fraction (45% Simpson’s 
method), mild mitral, aortic and tricuspid regurgita-
tion. In addition, an enlarged CS was found. During 
the PM implantation, the lead was advanced along 
the left border of the sternum (Fig. 2). The electrode 
was intentionally placed into one of the cardiac 
veins on the posterior wall of the LV, without CS 
visualization, but only a stylet preforming, with good 
electrical parameters. Pacing at 10 V did not cause 
any diaphragmatic stimulation. Finally, the LV pacing 
with the right bundle branch block morphology in 
a standard 12-lead ECG was obtained. The diagnosis 
of PLSVC was confirmed by angiography. Clinical 
improvement and ventricular arrhythmia reduction 
were observed during the follow-up. In January 
2013, after almost 10 years, the PM was changed 
due to a battery timeout.
Figure 1. Postero-anterior chest radiograph of AAT BiA 
pacemaker. Leads are passing through persistent left 
superior vena cava and are positioned in right atrium 
free wall and coronary sinus (Case 1).
Figure 2. Postero-anterior chest radiograph demon-
strates the ventricular lead in a postero-lateral cardiac 
vein (Case 3).
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Patient 4 (Case 4). A 75-year-old male was 
admitted to the hospital due to numerous presyncopal 
attacks and symptoms of congestive heart failure. His 
medical history included hypertension, permanent AF, 
diabetes mellitus, dyslipidemia and obesity (BMI = 35). 
Ambulatory ECG monitoring revealed many epi-
sodes of bradycardia < 40/min and pauses. The 
transthoracic echocardiography revealed dilated LV 
(end-diastolic diameter = 63 mm) with a normal ejec-
tion fraction, enlarged LA (52 mm) and a moderate 
mitral regurgitation. A passive fixation ventricular 
lead was inserted via the left subclavian vein, again the 
electrode advanced along the left edge of the sternum. 
Therefore, venography was performed intra-operative-
ly confirming the presence of PLSVC draining to the 
large CS. The J-shaped stylet was used to introduce 
the lead via the tricuspid annulus to the RVOT. The 
patient was discharged and remained free of symptoms 
ever since. An anticoagulation therapy was continued 
to prevent thromboembolic complications.
Results
During the mean follow-up period of 110 
months, pacing was effective. One patient (Case 1) 
required another operation and change of the pac-
ing mode due to progressive interatrial conduction 
prolongation during the follow-up. No serious 
complications related to the PM were observed. 
The basic data concerning parameters of pacing 
are presented in Table 2. Selected information 
obtained from 24-h ECG monitoring, symptoms 
related to arrhythmias like syncope, palpitations, 
and functional class (NYHA) during the follow-up 
are presented in Table 3.
Discussion
Historically, the first diagnosis of PLSVC 
could be made only by means of autopsy but at 
present, this anomaly may be diagnosed by several 
vital diagnostic examinations. A trans-thoracic 
echocardiography is the most relevant method 
for PLSVC recognition, especially with a contrast 
injection. The enlargement of the CS present in 
echocardiography should lead to PLSVC suspicion. 
However, visualization of the CS by trans-thoracic 
echocardiography is not possible in about 20% of 
patients. A contrast trans-esophageal echocardio-
graphy is necessary to exclude any other congeni-
tal cardiac malformations concomitant with this 
anomaly [13]. Another simple and cheap method 
is venography [14], which may be performed intra-
operatively during a PM implantation procedure. 
However, it should be avoided in patients with Ta
b
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severe renal dysfunction due to the risk of contrast 
nephropathy. In addition, magnetic resonance ima-
ging, computerized tomography and first pass ra-
dionuclide angiocardiography are useful but rarely 
performed methods in evaluation of PLSVC [15]. 
Despite all this advanced diagnostic methods, 
PLSVC is most often recognized during medical 
procedures such as central venous catheter inser-
tion, electrophysiological study, cardiac surgery 
and PM or cardioverter-defibrillator implantation. 
The presence of PLSVC may be suspected during 
the PM implantation on the basis of a left sided 
route of the electrode observed during fluoroscopy. 
In case of PLSVC, the proper positioning of a lead 
is difficult, the total time of procedure and the time 
of fluoroscopy are longer than usual.
Some authors suggest that PLSVC is coexist-
ent with arrhythmias. Rhythm abnormalities were 
observed in 36% in a series of 121 published cases 
with PLSVC and absence of the right superior vena 
cava [16]. A few mechanisms leading to arrhyth-
mias are distinguished:
— Histological changes in sinus and atrio-ven-
tricular nodes. A hypoplastic sinus node was 
reported in cases of absent right superior 
vena cava. An atrio-ventricular node also may 
have hypoplastic, fragmented and disorgan-
ized histological structure. Therefore, a DDD 
pacemaker should be considered in all cases 
of PLSVC and a sick sinus syndrome. The 
proximal part of the great thoracic veins con-
tains cardiac muscles connected to the atrium. 
Some of the cardiomyocytes have their own 
PM activity and may be responsible for the 
arrhythmic activity [17]. Hsu et al. [6] studied 
5 patients with PLSVC and symptomatic drug 
refractory AF after a pulmonary vein isolation. 
Many electrical connections between PLSVC 
and CS and the LA were documented during 
an electrophysiological examination. Addi-
tionally, repetitive ectopic beats originating 
from PLSVC were observed. In each case, the 
ectopic beats initiated AF. Electrical activity 
of PLSVC and many electrical connections 
between PLSVC and the LA, and between 
PLSVC and CS were reported by Maruyama 
et al. [7] in a 25-year-old man with a Wolff-
-Parkinson-White syndrome, who underwent 
radiofrequency ablation. Thus, the electrical 
properties of PLSVC may play a role in the 
genesis of atrial tachyarrhythmias.
 The prevalence of accessory pathways in the 
group of patients with PLSVC is higher than 
in general population [18]. Most often, these 
are left free wall and posteroseptal pathways, 
which are remnants of incomplete separation 
of myocardium between atria and ventricles 
by the annulus fibrosis during cardiogenesis.
— Prolonged interatrial conduction may consti-
tute another problem in patients with PLSVC. 
It is known that delayed LA depolarization de-
teriorates hemodynamic function of the heart 
leading to concurrent (instead of sequential) 
LA and LV contraction and may induce AF. The 
interatrial conduction time may be prolonged 
before the PM implantation. Chan et al. [19] 
described a 63-year-old man with paroxysmal 
AF and widened P-wave (130 ms) in ECG. 
A DDD BiA pacemaker was implanted via 
PLSVC and the patient was free of AF recurrence 
without antiarrhythmic medications during the 
6-month follow-up. Similar result was obtained 
in our patient no. 1, after upgrading to BiA 
pacing. A prolongation of interatrial conduction 
time may also appear after a typical RAA and 
especially RA free wall electrode placement. 
BiA pacing may prevent hemodynamic and 
electrical consequences. This should be con-
sidered in patients with PLSVC because it is 
difficult to place the atrial lead into the RAA, 
or septal position and CS ostium offers insuf-
ficient sensing. In our Case 1, the interatrial 
conduction time was long after PM implanta-
tion (P-wave duration 160 ms) and became 
even longer during the follow-up (200 ms). 
After changing the mode of pacing from AAI 
to AAT BiA the P-wave duration shortened to 
120 ms. A clinically good result in prevention 
of paroxysmal AF was confirmed.
 PLSVC as a sole anomaly has no influence on 
hemodynamics and does not take part in the 
development of heart failure directly. How-
ever, concomitant arrhythmias may precipitate 
a heart failure. Atrial tachyarrhythmias with 
a rapid ventricular rate reduce ventricular 
filing and cardiac output and may even lead 
to tachycardiomyopathy. On the other hand, 
marked bradycardia also depresses cardiac 
output. Depressed hemodynamic function 
and irregular rhythm may induce ventricular 
arrhythmias. The non-sustained ventricular 
tachycardia observed in Case 3 was probably 
induced by severe bradycardia and did not 
occur after PM implantation (Table 3).
One of the main purposes of our report was to 
demonstrate safety of the cardiac pacing via PLSVC 
in a long-term follow-up. Almost all cases present-
ed in the literature have short follow-up periods, 
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which do not allow assessing the consequences 
of electrodes presence in PLSVC on the PM and 
heart function. Biffi et al. [20] implanted 2 PM and 
2 cardioverter-defibrillators via PLSVC. After 41 
months no device malfunction or lead dislodgement 
were observed. No complications occurred during 
the 4-year follow-up in another patient with DDD 
pacemaker implanted via PLSVC [21].
In Cases 2 and 4, ventricular leads were im-
planted into the right ventricle septal aspect of 
the outflow tract. This position of the lead seems 
hemodynamically more profitable than the classic 
right apical (RVA) pacing and is easier to achieve 
via PLSVC. In Case 3, the passive fixation bipolar 
lead was advanced into the left postero-lateral vein 
via PLSVC. This route was also used by Gaba et 
al. [22] during a DDD pacemaker implantation but 
an over-the-wire electrode was used after the CS 
venography. In our case, leads dedicated for the LV 
pacing were not available at that time.
Conclusions
1. The presence of PLSVC may complicate pace-
maker’s implantation.
2. Yet, it does not influence the long-term follow-
-up of pacing parameters.
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